Study of the Consumer Use of a New Home Test to Measure Sperm Concentration
Status: | Completed |
---|---|
Conditions: | Women's Studies |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | 20 - 50 |
Updated: | 10/20/2017 |
Start Date: | September 2, 2015 |
End Date: | November 2015 |
A Clinical Study Evaluating Consumer Use of a New Device (TRAK) to Measure Sperm Concentration From Human Semen Samples, and Comparing TRAK Test Results With Laboratory Reference Method Testing
The objective of the study is to evaluate the agreement in measurement of sperm concentration
in human semen between lay users with TRAK and a recognized reference method. The study will
also include the measurement of matched samples by TRAK when tested by healthcare
professionals trained in use of the TRAK device.
in human semen between lay users with TRAK and a recognized reference method. The study will
also include the measurement of matched samples by TRAK when tested by healthcare
professionals trained in use of the TRAK device.
Inclusion Criteria:
Subjects (Donor/Tester)
- Generally healthy (apart from fertility or reproductive care), ambulatory, and have
absence of chronic conditions or treatments, except those related to fertility and
reproductive care
- 20 - 50 years of age inclusive
- Male sex (subjects providing and/or testing human semen specimens)
- For males providing human semen specimens, either healthy subjects or men receiving
health care for any one or more of the following reasons:
- Partner in a couple having difficulty conceiving
- Diagnosed with male factor infertility
- Post-vasectomy patients
- Post-vasectomy reversal patients
Testers Only
- Be able to provide signed Informed Consent
- 20 - 50 years of age inclusive
Exclusion Criteria:
- Any medical or personal issue that would impair the ability of the subject to adhere
to the protocol (e.g. substance abuse, neurological disorders)
- Patients currently taking investigational drugs or who are active participants in a
treatment trial for any condition
- Unable to speak, understand, or write English
- Mental illness that would interfere with understanding during the discussion of
Informed Consent or that would compromise ability to follow the study protocol
including, but not limited to, review of the TRAK™ Instructional Booklet, semen
specimen collection, and semen specimen testing.
We found this trial at
3
sites
Tarzana, California 91536
Principal Investigator: Eugene Dula, MD
Phone: 818-996-4242
Click here to add this to my saved trials
Encino, California 91436
Principal Investigator: Robert Boostanfar, MD
Phone: 818-788-7288
Click here to add this to my saved trials
Great Neck, New York 11021
Principal Investigator: Bruce Gilbert, MD
Phone: 516-487-2700
Click here to add this to my saved trials